Company news
Asahi Kasei Corporation (TSE:3407) news
Every Asahi Kasei Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Asahi Kasei : Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
August 31, 2026
Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy
August 26, 2026
Asahi Kasei : Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy
August 26, 2026
Asahi Kasei : Contract Signed with JOGMEC for Design Work Related to Ship-Based Advanced CCS Project
August 24, 2026
Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries
August 20, 2026
Asahi Kasei’s Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives
August 19, 2026
Asahi Kasei : Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives
August 18, 2026
Results and completion of repurchase of shares
August 17, 2026
Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China
August 6, 2026
Asahi Kasei : Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China
August 5, 2026
Asahi Kasei : Notice regarding status of share repurchase
August 2, 2026
Asahi Kasei : Financial Results Presentation Material, first quarter fiscal 2026
July 31, 2026
Consolidated Results for 1st Quarter Fiscal 2026
July 30, 2026
Asahi Kasei Microdevices Begins Mass Production of Camera‑less Modules for Detection of Falls, Vital Signs, Posture, and Position
July 15, 2026
Asahi Kasei Adds New Slitting Facility for SUNFORT™ to Meet Growing Demand for Advanced Semiconductor Packaging
July 7, 2026
Notice regarding status of share repurchase
June 30, 2026
Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time
June 25, 2026
Asahi Kasei : Results of Vote at the 135th Ordinary General Meeting of Shareholders
June 24, 2026
EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei’s Novel Electrolyte Acetolyte™
June 2, 2026
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute - A Major Milestone for More Efficient and Safer Cancer Treatments
May 28, 2026
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments
May 27, 2026
Asahi Kasei Develops Novel Photosensitive Polyimide Film for Advanced Panel-Level Semiconductor Packaging
May 21, 2026
Asahi Kasei : Teijin Frontier and Asahi Kasei Advance Announce New Company Name Ahead of Planned Business Integration
May 18, 2026
Asahi Kasei : Begins Phase III Clinical Trial of Teriparatide Acetate for Patients with Osteoporosis at High Risk of Fracture
May 17, 2026
Battery Separator Research Report 2026: A Global $78.97 Billion Market by 2040 Featuring Notable Players - Asahi Kasei, Bernard Dumas, Sinoma Lithium Film, SK Innovation, and Toray
May 13, 2026
Asahi Kasei Optimizes Material Portfolio Through Supply Realignment by FY2030
May 12, 2026
Asahi Kasei : Financial Results Presentation Material, fiscal 2025
May 11, 2026
Asahi Kasei : Optimizes Material Portfolio Through Supply Realignment by FY2030 （474.4KB）
May 11, 2026
Asahi Kasei : Notice of payment of dividends from surplus (increased dividend) and forecast of dividends （116.7KB）
May 11, 2026
Asahi Kasei : Notice regarding status of share repurchase （61.5KB）
April 30, 2026
Asahi Kasei : filed litigation for infringement of patent rights of Duranol™ in China
April 23, 2026
Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy
April 20, 2026
Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases
April 20, 2026
Calliditas Therapeutics AB to Present Exploratory Biomarker and Post-Hoc NefIgArd Analyses at the World Congress of Nephrology
March 30, 2026
Chevron Technology Ventures, Asahi Kasei Invest in Heavy-Industry Robotics Company KEWAZO
March 19, 2026
Tanahashi Prize Recognizes the Robust Long-Term Operation of the 10MW Alkaline-Water Electrolysis System by Asahi Kasei
March 19, 2026
Asahi Kasei, Nippon Steel, and Nippon Steel Trading Recycle Chlor-Alkali Electrolysis Cell Production Scrap Back into High-Quality Pure Titanium
March 18, 2026
Asahi Kasei Begins Installation of Containerized Alkaline-Water Electrolyzer at Finland’s First Commercial Hydrogen Refueling Station
March 12, 2026
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris
February 26, 2026
Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases
February 26, 2026
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds
February 25, 2026
IEEE Recognizes Asahi Kasei Microdevices’ Commercialization of Thin-Film Hall Elements as an IEEE Milestone
February 19, 2026
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases
February 18, 2026
ZOLL Medical Appoints Eric Knudsen as New CEO
February 4, 2026
Asahi Kasei Develops PFAS-Free PA66 Offering Low-Friction and High-Load Performance
January 29, 2026
Bionique Testing Laboratories Appoints Dr. Andy Bailey, Strengthening Global Biosafety Testing
January 28, 2026
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical enter basic agreement to promote decarbonization of ethylene production in western Japan
January 27, 2026
ZOLL Strengthens Growth Trajectory for Asahi Kasei’s Healthcare Sector with U.S. Launch of the Next-Generation LifeVest® WCD and Rollout of the Most Comfortable LifeVest Garment Ever, Reinforcing Position as Leader in WCD Category
January 8, 2026
Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark
December 22, 2025
Asahi Kasei Microdevices and Aizip Deliver Transformative AI-Enhanced Sensing Solutions
December 16, 2025